Zyla Life Sciences Operating Cash Flow
Zyla Life Sciences reported Operating Cash Flow of $5.33 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2020-05-14
- Zyla Life Sciences net cash provided by (used in) operating activities for the quarter ending 2020-03-31 was $5.33M.
- Zyla Life Sciences net cash provided by (used in) operating activities for the quarter ending 2018-12-31 was -$9.03M.
- Zyla Life Sciences net cash provided by (used in) operating activities for the quarter ending 2018-09-30 was -$19.78M.
- Zyla Life Sciences net cash provided by (used in) operating activities for the quarter ending 2018-06-30 was -$5.35M.
- Zyla Life Sciences net cash provided by (used in) operating activities for fiscal 2018 was -$54.81M.
- Zyla Life Sciences net cash provided by (used in) operating activities for fiscal 2017 was -$65.16M.
- Zyla Life Sciences net cash provided by (used in) operating activities for fiscal 2016 was -$72.87M.
- Zyla Life Sciences net cash provided by (used in) operating activities for fiscal 2015 was -$38.91M.
| Period end | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 2 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 5 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 8 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 11 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $5.33M 10-Q · filed 2020-05-14 | ||||||||
| 2019-12-31 | -$10.96M 10-K · filed 2020-03-26 | ||||||||
| 2019-09-30 | -$6.99M 10-Q · filed 2019-11-14 | ||||||||
| 2019-06-30 | -$13.78M 10-Q · filed 2019-08-13 | ||||||||
| 2019-03-31 | -$16.40M 10-Q · filed 2020-05-14 | ||||||||
| 2019-01-31 | $822.00K 10-Q · filed 2020-05-14 | ||||||||
| 2018-12-31 | -$9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$28.81M derived: sum of 2 quarters · filed 2020-03-26 | -$34.15M derived: sum of 3 quarters · filed 2020-03-26 | -$54.81M 10-K · filed 2020-03-26 | |||||
| 2018-09-30 | -$19.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$25.13M derived: sum of 2 quarters · filed 2019-11-14 | -$45.79M 10-Q · filed 2019-11-14 | -$55.78M derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | -$5.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$26.01M 10-Q · filed 2018-08-09 | -$36.00M derived: sum of 3 quarters · filed 2019-03-29 | -$50.10M derived: sum of 4 quarters · filed 2019-03-29 | |||||
| 2018-03-31 | -$20.66M 10-Q · filed 2018-05-10 | -$30.66M derived: sum of 2 quarters · filed 2019-03-29 | -$44.76M derived: sum of 3 quarters · filed 2019-03-29 | -$65.22M derived: sum of 4 quarters · filed 2019-03-29 | |||||
| 2017-12-31 | -$10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$24.09M derived: sum of 2 quarters · filed 2019-03-29 | -$44.56M derived: sum of 3 quarters · filed 2019-03-29 | -$65.16M 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | -$14.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | -$34.56M derived: sum of 2 quarters · filed 2018-11-19 | -$55.17M 10-Q · filed 2018-11-19 | -$70.96M derived: sum of 4 quarters · filed 2018-11-19 | |||||
| 2017-06-30 | -$20.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$41.07M 10-Q · filed 2018-08-09 | -$56.86M derived: sum of 3 quarters · filed 2018-08-09 | -$77.98M derived: sum of 4 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | -$20.61M 10-Q · filed 2018-05-10 | -$36.40M derived: sum of 2 quarters · filed 2018-05-10 | -$57.52M derived: sum of 3 quarters · filed 2018-05-10 | ||||||
| 2016-12-31 | -$15.79M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$36.91M derived: sum of 2 quarters · filed 2018-03-16 | -$72.87M 10-K · filed 2018-03-16 | ||||||
| 2016-09-30 | -$21.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$57.08M 10-Q · filed 2017-11-08 | |||||||
| 2016-06-30 | -$35.96M 10-Q · filed 2017-08-09 | ||||||||
| 2015-12-31 | -$38.91M 10-K · filed 2018-03-16 |